Taro Announces Completion of $250 Million Share Repurchase Program

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it recently completed its $250 million share repurchase program. The company bought back 1,801,099 of its ordinary shares in open market transactions at an average price of $138.80 per share. The repurchase program was announced by the company on March 15, 2016, and was completed on August 18, 2016.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160819005714/en/

Taro Pharmaceutical Industries Ltd.
William J. Coote, 914-345-9001
[email protected]

Source: Taro Pharmaceutical Industries Ltd.

You May Also Be Interested In

• What the XRP ICO Can Teach Us About Finding the Next 100x Crypto To Buy Today
• Patrina & Charles White of Sucre Realty Recognized Among Houston's Leading Realtors Following More Than 60 Million in Career Sales and Service to Over 100 Families
• FROM YOUNGSTAR TO GRAND SLAM CHAMPION: LINDA NOSKOVÁ CONQUERS WIMBLEDON